MD Anderson Theraclone Sciences form OncoResponse
Latest Breast Cancer News from BioPortfolio
MD Anderson Theraclone Sciences form OncoResponse
Immunooncology antibody discovery focus of company to be based in Houston OncoResponse an immunooncology antibody discovery company has been launched jointly by The University of Texas MD Anderson Cancer Center and
AiRS to Host Silent Auction Fundraiser for Breast Cancer Survivors
The Alliance in Reconstructive Surgery AiRS and cofounding board member Dr. Rod J. Rohrich will host a special fundraising event this Thursday October 8th from 700pm to 1000pm.Dallas Texas PRWEB October 06 2015 The Alliance in Reconstructive Surgery AiRS ...
Comments
Post a Comment